Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
24.39
-0.10 (-0.41%)
Nov 21, 2024, 1:17 PM EST - Market open
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.94 billion as of November 21, 2024. Its market cap has decreased by -1.68% in one year.
Market Cap
1.94B
Enterprise Value
1.19B
1-Year Change
-1.68%
Ranking
Category
Stock Price
$24.39
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.94B, an increase of 491.89%. That is a compound annual growth rate of 44.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.95B | -9.73% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | 327.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 1.97B |
| Wave Life Sciences | 1.96B |
| GeneDx Holdings | 1.95B |
| Supernus Pharmaceuticals | 1.95B |
| NeoGenomics | 1.93B |
| National HealthCare | 1.91B |
| Tandem Diabetes Care | 1.89B |
| Harmony Biosciences Holdings | 1.89B |